This inventor holds 1 USPTO granted patent. Top assignee: Syntex (u.s.a.) Inc.. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: Sayee Gojanan Hegde: Innovator in Pharmaceutical Formulations
Introduction
Sayee Gojanan Hegde is a notable inventor based in Los Angeles, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of oral suspensions.
Latest Patents
Hegde holds a patent for "Mycophenolate mofetil high dose oral suspensions." This invention involves high dose, dry granulations or powder blends and aqueous oral suspensions of mycophenolate mofetil or mycophenolic acid. The formulation contains an active compound (7.5-30%), a suspending/viscosity agent, sweetener, flavor, and a buffer to maintain a pH of 5-7.5. Additionally, it may include a flavor enhancer, wetting agent, antimicrobial agent, and color.
Career Highlights
Hegde is associated with Syntex (U.S.A.) Inc., where he has been instrumental in developing innovative pharmaceutical products. His work has contributed to advancements in medication delivery systems, enhancing patient compliance and treatment efficacy.
Collaborations
Hegde collaborates with esteemed colleagues, including Deborah M. Lidgate and Li-hua Wang-Kessler, who contribute to the research and development efforts within the company.
Conclusion
Sayee Gojanan Hegde's innovative work in pharmaceutical formulations exemplifies the impact of dedicated inventors in improving healthcare solutions. His contributions continue to shape the future of medication delivery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile